GlassScriptPhysician profile
Larry Clay Ballinger
NPI 1659326783
$2,656.32
in general payments reported to CMS, 2019-2025
13 companies · $92.80 in 2025
The $92.80 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2021: $595 · 2022: $1,302 · 2023: $274 · 2024: $17.26 · 2025: $92.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elevate Surgical Co | $1,258.92 | 2022 | |
| Stryker Corporation | $609.43 | 2021-2025 | Pulse Point, Ortholoc 3di Crosscheck, Spy-Phi System |
| Treace Medical Concepts, INC. | $364.41 | 2019-2025 | |
| Arthrex, INC. | $189.34 | 2023 | |
| Djo, LLC | $47.27 | 2019-2023 | Cmf |
| Amgen INC. | $41.25 | 2022-2023 | Evenity, Prolia |
| Averitas Pharma INC. | $28.00 | 2025 | Qutenza |
| Kerecis Limited | $26.22 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $24.00 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.34 | 2022 | |
| Depuy Synthes Sales INC. | $17.26 | 2024 | Motoband |
| Misonix INC | $16.06 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.82 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Ballinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.